INDIANAPOLIS, IN -- (MARKET WIRE) -- May 21, 2007 -- Data suggest that patients with generalized anxiety disorder (GAD) treated with Cymbalta® (duloxetine HCl) experienced improved ability to perform everyday activities at home, work and in social situations compared to sugar pill. These improvements in global functioning were the result of improvements in anxious symptoms, as well as through an improvement in the painful physical symptoms that can be associated with the condition. The results of these data from two GAD registration studies of more than 840 patients were presented today at a major medical meeting of psychiatrists.
